Ventas (VTR) Q4 2024 earnings summary

Executive summary

• Delivered strong 2024 results with normalized FFO per share up 7% to $3.19, exceeding guidance, driven by double-digit SHOP NOI growth and over $2 billion in accretive senior housing investments.

• Increased quarterly dividend by 7% to $0.48 per share, reflecting robust performance and a positive outlook for 2025.

• Expanded investment team, including a new Senior Managing Director, to capitalize on external growth opportunities.

• Liquidity stood at $3.8 billion at year-end 2024, with leverage improved to 6.0x Net Debt to EBITDA, within the long-term target range.

Financial highlights

• Full-year normalized FFO per share reached $3.19, a 7% year-over-year increase, exceeding the high end of guidance; Nareit FFO per share was $3.14.

• Fourth quarter normalized FFO per share was $0.81, up 7% year-over-year; attributable net income per share was $0.19.

• Total company same-store cash NOI grew 7.7% year-over-year, led by 15.8% growth in SHOP; U.S. SHOP NOI up 18.1%.

• Outpatient medical and research NOI grew 3% in 2024; triple-net segment up 1.8%.

• Ended 2024 with nearly $4 billion in liquidity.

Outlook and guidance

• 2025 normalized FFO per share guidance is $3.35–$3.46 (midpoint $3.41), representing 7% year-over-year growth.

• 2025 same-store cash NOI expected to grow 6.75% at the midpoint, led by SHOP; SHOP same-store NOI projected to grow 11–16% with ~270bp occupancy gains.

• $1 billion in senior housing investments planned for 2025, primarily equity funded; $200 million in asset dispositions expected.

• Net interest expense projected to increase by $32 million year-over-year in 2025 due to higher rates.